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Available online 2 May 2014Protein disulfide-isomerase (PDI) is a four-domain flexible protein that catalyzes the formation of
disulfide bonds in the endoplasmic reticulum. Here we have analyzed native PDI purified from
humanplacenta by chemical cross-linking followedbymass spectrometry (CXMS). In addition to
PDI the sample contained soluble calnexin and ERp72. Extensive cross-linking was observed
within the PDI molecule, both intra- and inter-domain, as well as between the different compo-
nents in the mixture. The high sensitivity of the analysis in the current experiments, combined
with a likely promiscuous interaction pattern of the involved proteins, revealed relatively
densely populated cross-link heat maps. The established X-ray structure of the monomeric PDI
could be confirmed; however, the dimer as presented in the existingmodels does not seem to be
prevalent in solution as modeling on the observed cross-links revealed new models of dimeric
PDI. The observed inter-protein cross-links confirmed the existence of a peptide binding area on
calnexin that binds strongly both PDI and ERp72. On the other hand, interaction sites on PDI and
ERp72 could not be uniquely identified, indicating a more non-specific interaction pattern.
Biological significance
The present work demonstrates the use of chemical cross-linking and mass spectrometry
(CXMS) for the determination of a solution structure of natural human PDI and its interaction
with the chaperones ERp72 and calnexin. The data shows that the dimeric structure of PDI may
be more diverse than indicated by present models. We further observe that the temperature
influences the cross-linking pattern of PDI, but this does not influence the overall folding pattern
of the molecule.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Keywords:
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Placenta1. Introduction
Elucidating the structure of proteins is an essential part of
molecular structure-function studies. However, despite the fact
that theaminoacid sequence is known formost proteinsofmanyup).
by Elsevier B.V. This
c-sa/3.0/).species, the structure ofmanyproteins remainsunknownor only
partly characterized. This is due mainly to limitations in the
availability of the proteins and in the methods used for protein
structure elucidation.
X-ray crystallography has for many years been the major
method for detailed structure elucidation of proteins [1–6].
This method requires relatively large amounts of pure protein
and is limited to proteins, which form suitable crystals. Largeis an open access article under the CC BY-NC-SA license
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technology; however, this often does not lead to suitable
crystals. Obstacles to this include inherent mobility or
flexibility in multi-domain proteins, heterogeneity, or a lack
of a well-defined structure. In such cases, structural infor-
mation may be obtained for crystallizable domains or for
defined parts of the protein. Even so, X- ray crystallography
can only give information about solid state structures of
proteins and for many proteins, particularly enzymes,
molecular dynamics is vital to the function, e.g. for PDI,
which must be able to break improper disulfide bonds and to
join the proper ones.
Protein disulfide isomerase (PDI), a 57 kDa protein com-
posed of four thioredoxin domains, two oxido-reductase
domains (a and a′) with CGHC active sites, two non-catalytic
domains (b and b′), a linker region between domains b′ and a′,
and a C-terminal acidic tail [7–9]. The main responsibility of
disulfide bonds is to stabilize protein structures, while in
some proteins the cysteines perform redox regulation of
enzymatic activity. Approximately one third of human
proteins contain disulfide bonds [10], and the formation of
disulfide bond limits the rate of protein synthesis. Protein
disulfide isomerase (PDI), was published in 1963 as the first
folding catalyst [11]. It catalyzes disulfide bond formation,
breakage and rearrangement, and thus assists proper
protein folding [12,13]. PDI is mainly expressed in the
endoplasmic reticulum (ER), but also on the cell surfaces of
lymphocytes, hepatocytes, and platelets [14,15]. In the ER it
also takes part in peptide loading onto major histocompati-
bility complex class I [16], as well as regulating NAD(P)H
oxidase [17].
Although PDI was discovered more than 50 years ago, a
complete X-ray structure was not solved until 7 years ago for
yeast PDI (yPDI) [18] and has only recently been obtained for
human (hPDI) PDI [19]. On the way to solve the full structure,
X-ray crystallography models for individual domains were
solved and yielded important information about the active
sites and substrate binding sites [18,20–22].
Nuclear magnetic resonance (NMR) spectroscopy can yield
information about structure and dynamics for proteins in
solution and can be used for proteins up to 100 kDa but also
requires large amounts of pure protein, which must not
aggregate in solution [23–32]. For PDI, NMR spectroscopy has
yielded important information about the structure and
dynamics of several domains [33–38] but not yet the whole
enzyme.
Small angle X-ray scattering (SAXS) can yield low resolu-
tion structural information for proteins in solution, but has
the same requirements for sample amount and purity as NMR
spectroscopy [31,39–43]. For PDI, SAXS has shown an annular
arrangement of the four domains [44].
Thus, the above methods each have their advantages and
disadvantages, but all are challenged by the requirement for
sample purity. Here, we show, using PDI and other endoplas-
mic reticulum (ER) proteins, that chemical cross-linking
in combination with mass spectrometry (CXMS) can yield
relevant information about the structure, internal dynamics
and intermolecular interactions for low concentrations of
mixtures of native proteins in solution. CXMS is particularly
useful in combination with known structural models obtainedby the methods described above and when handling proteins
from natural sources, that have not been obtained in a very
high purity.2. Materials and methods
2.1. Materials
NaH2PO4, Na2HPO4, NH4HCO3, CH3CN and TFA were from
Sigma Aldrich (St. Louis, MO). Bis[sulfosuccinimidyl] suberate
(BS3) was obtained from Thermo Scientific Pierce (Rockford,
IL). Porcine trypsin was a gift from Novo Nordisk (Copenha-
gen, Denmark). Spin filters were from Sertorius Stedim
Biotech (Bohemia, NY). Poros Oligo R2 and R3 50 were from
Applied Biosystems (Foster City, CA). ReproSil Pur C18 AQ
3 μm was from Dr Maisch GMBH (Ammerbuch-Entringen,
Germany). Pure water was obtained from an Elga PureLab Flex
(Marlow, UK).
2.2. Purification of PDI
PDI was obtained during purification of human placenta
chaperones as described elsewhere [45]. In short, a placenta
was homogenized with Triton X-114, the supernatant was
separated by temperature-dependent phase separation, and
the supernatant from this was precipitated by ammonium
sulfate. The new supernatant was ultradiafiltrated, and the
retentate was applied to a Q Sepharose Fast Flow column
equilibratedwith 20 mMTris, 1 mMCaCl2, pH 7.5. Proteinswere
eluted with a gradient of NaCl (0–0.5 M). Eluted proteins were
monitored by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and enzyme-linked immunosor-
bent assay (ELISA) using antibodies directed against calreticulin,
calnexin, ERp57, ERp72 and PDI. The fraction used for the
current analysis corresponds to fractions 132–136 in Fig. 3 of
[45]. Two different preparations were used, one for the room
temperature experiment, and one for the low/high temperature
experiments.
2.3. Cross-linking
50 μg sample (fraction 132–136) was transferred to phos-
phate buffer (25 mM, pH 7.5) to a concentration of 2 μg/μL
using 10 kDa spin filter. Before adding cross-linkers, sam-
ples were equilibrated for 30 min under different tempera-
tures, 0 °C on ice water, room temperature and 37 °C
separately in a thermostat. Following equilibration, an
equal volume of phosphate buffer containing 2500 μg BS3
was added to the samples to a final ratio of 1:50 w/w protein:
cross-linker (approximate molar ratio of 1:376), and the
cross-linking reactions were carried out under the same
temperatures as the equilibration step. After 1 h, the
reaction was terminated by the addition of 1 M NH4HCO3
to a final concentration of 20 mM NH4HCO3. After 20 min,
the samples were reduced, alkylated and digested by 2%
trypsin w/w at 37 °C overnight. Two different batches
containing the same proteins in different amounts were
used, one for the room temperature assay and another for
the 0 °C and 37 °C experiments.
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The samples were reduced by adding dithiothreitol to a
concentration of 5 mM, incubating at 56 °C for 30 min followed
by alkylation by iodoacetamide (10 mM) at room temperature
for 30 min. Digestion of the protein was performed with 2%
trypsin (w/w) overnight at 37 °C, and the resulting peptideswere
separated by strong cation exchange (SCX) chromatography
using a polySULFOETHYL A, 150 × 1 mm, 5 μm particle size,
300 Å pore size column (PolyLC Inc., Columbia, MD). The buffer
gradient was: 0–0% B (10 min); 0–40% B (30 min); 40–90% B
(5 min); and 100% B (5 min) at a flow rate of 50 μL/min (A buffer,
30%ACN, 0.1% TFA; B buffer, 30%ACN, 0.1% TFA, 500 mMNaCl).
The separationwas performed on anAgilent 1200 HPLC (Agilent
Technologies)monitored at 214/254/280 nm. The entire runwas
manually collected and divided into 4 fractions. Each fraction
was desalted using homemade Poros Oligo R2/R3 (R2:R3 ratio:
4:1) RP microcolumns [45].
2.5. Mass spectrometry
The desalted peptides were loaded onto a 100 μm inner
diameter and 18 cm RP capillary column (homepacked with
ReproSil Pur C18 AQ 3 μm sorbent) in buffer A (0.1% formic
acid, 5% ACN) and run on a Proxeon 1100 easy-nLC system
(Thermo Fisher Scientific/Proxeon Biosystems, Odense,
Denmark).
The peptides were eluted using either a 50 min gradient
(protein identification) or an 80 min one (cross-link identifi-
cation) from 0 to 34% B-buffer (95% ACN, 0.1% formic acid) at
350 nL/min flow rate and via nanoelectrospray introduced
into an LTQ-Orbitrap XL mass spectrometer (Thermo Fisher
Scientific, Bremen, Germany). A full MS scan in the mass area
of 300–1800 m/z was performed in the Orbitrap with a
resolution of 30,000 FWHM and a target value of 1 * 10(6)
ions. For each full scan the top five ions were selected for
either collision induced dissociation (CID) for protein identi-
fication or for high energy collision dissociation (HCD) for
cross-link identification. CID settings were as follows, activa-
tion time, 30 ms; isolation width, 2.5; normalized collision
energy, 35; repeat count, 1; repeat duration, 30; and exclusion
duration, 45. HCD settings were as follows: threshold for ion
selection, 15,000; target value of ions used for HCD 2 * 10(5);
activation time, 10 ms; isolation width, 2.5; normalized
collision energy, 42; repeat count, 1; repeat duration, 30; and
exclusion duration, 45.
2.6. Data analysis
Raw data were converted to mgf format by Proteome Discover
1.4 (Thermo Fisher Scientific). The data were further filtered
by MGF Filter V0.104 to retain only the top 125 most intense
peaks per scan (in-house built software, now included in the
MassAI search tool). For protein identification the data were
searched by the MassAI search engine against the Homo
sapiens part of the UNIProt database with the parameters of
10 ppm MS accuracy, 0.1 Da MS/MS accuracy, trypsin as
enzyme, three allowed missed cleavages, carbamidomethyl-
ation of cysteine as fixed modification, and oxidation of
methionine as variable modifications. Based on the proteinsidentified, a database including only these proteins was
generated. Results were further verified by searching the
same dataset by the Mascot search engine (Matrix Science,
UK).
Searches for crosslinked peptides were conducted against
this database using the CrossWork algorithm [46]. The initial
searches were carried out using the original CrossWork
software (www.massai.dk) with the following parameters,
cross-linker: BS3; protease: trypsin with allowance for 3
missed cleavages, fragmentation mode: CID/HCD; MS toler-
ance: 0.010 Da; MS/MS tolerance: 0.025 Da; cross-link search
modes included mass matching, level 1 and level 2 search, as
described [46]. During preparation of this paper, the
CrossWork algorithm itself was incorporated into the MassAI
analytical software package (in-house developed; www.
massai.dk). The latter was then used for constructing the
cross-link heat maps, using search parameters identical to
the CrossWork searches. When constructing the heatmaps,
low scoring scans (score < 10) were excluded. Representative
scans for the cross-links discussed were annotated and
exported (Supplementary Fig. 3).
2.7. Modeling
Two complete structures of human PDI are publicly available,
both determined by X-ray crystallography, known as oxidized
PDI (4EL1) [19] and reduced PDI (4EKZ) [19]. As our experimen-
tal conditions closely match that of the oxidized version, all
our further structure analyses are based on the PDI confor-
mation solved in the above-mentioned redox state.
The crystal structure of hPDI, 4EL1, shows two PDImolecules
in the asymmetric unit with the a domain of one molecule
nested between the a′ and the a domain of the other. This is
likely a result of crystallization, and the dimer of the hPDI
molecule is still missing. Whereas for the yeast, Tian et al. have
shown that the yPDI has a propensity to dimerize in solution
and have deposited the structure in PDB with the code 3BOA.
1. Dimer structure
When aligning yeast and hPDI the sequence identity is 31%.
Due to the low sequence identity of yeast andhumanPDI (not
all cross-linked Lys residues are conserved in yeast) it is
rather complicated to use it in our analysis, thus a model
using the yeast conformation as a template has been
constructed. We keep in mind, that the structure of
full-length yPDI cannot represent the structure of hPDI,
because they are not functionally equivalent and are
dissimilar in several aspects, but due to the absence of
structural information on the hPDI dimer, we overcome the
problem by modeling the hPDI dimer based on yPDI. The
following steps have been performed to obtain the
above-mentioned dimer structure, in the following called
hYeastDimer:
1. As a first step a sequence similarity search on the nr
database March 28, 2014 using two iterations of CS-Blast
has been performed.
2. We selected the top 100 multiple sequence alignment
having an e-value lower than 1e-103.
3. The sequences obtained in the previous step together
with the 2 structures i.e. pdb code 4EL1 and 3BOA have
80
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alignment of the two above-mentioned structures using
PROMALS3D.
4. The sequence alignment has subsequently been used to
build the three-dimensional model of hPDI using
Modeller (Fig. 6).
2. Dimeric structure cross-link list
In order to exclude the cross-links that were observed to fit
the monomer model, all the intra-protein Cα cross-link
distances have been calculated using the hPDB structure
4EL1 (as a first step all the coordinates of missing residues in
the 4EL1 structure have been modeled using Modeller [47])
and the hYeastDimermodel with 30 Å threshold (the sumof
the length of a BS3 cross-linker and lysine side chains and 5 Å
for flexibility). Out of 261 total cross-links identified at room
temperature only 123 fitted themonomeric structure of 4EL1
and 117 the hYeastDimer one. The remaining 138 and 144
cross-links were in discordance thus suggesting the exis-
tence of alternative conformations.
3. Cross-link ambiguity
The 138 cross-links that were in discordance with the 4EL1
structure have been sorted according to the copy number
in order to identify the most reliable ones. The total
number of cross-links considered for further data analysis
was equal to 10 (the number of cross-links seen more than
5 times; this number being a sum of mean (2.6) + sd (2.2) of
the data). But since the hPDI is a homodimer, the cross-link
list determined experimentally between the residues X
and Y and obtained in the previous step can be represented
by 2 scenarios:
1. an inter-protein cross-link between the residue X of
chain A and the residue Y of chain B
2. an inter-protein cross-link between the residue X of
chain B and the residue Y of chain A.1 2 3 4
15
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Fig. 1 – SDS PAGE of the proteins used for cross-linking. Lane
1: molecular marker; lane 2: non-cross-linked proteins; lane
3–5: proteins cross-linked by BS3 at room temperature (lane
3) at 0 °C (lane 4) and at 37 °C (lane 5). Proteins in lane 2 are a,
b: calnexin; c: PDI; d: ERp72.Therefore, the total number of the most reliable 10 cross-
links should bemultiplied by two resulting in 20 cross-links,
but since one of the cross-links is symmetrical (the residue
54 does a cross-link with itself, there is no need to consider 2
scenarios i.e. residue 54 chain A–residue 54 chain B and vice
versa as in the remaining 9 cases). 19 cross-links have been
selected for the further conformational searches to produce
models of the corresponding dimer complexes.
4. Dimer complex search
Dimer models of PDI were created based on the monomeric
unit of 4EL1 using the RosettaDock modeling suite (http://
www.rosettacommons.org). RosettaDock is awell-established
docking protocol that incorporates physical and empirical
energy functions and fast conformational searching
techniques. The algorithm searches the rigid-body and
side-chain conformational space of two interacting proteins,
making it suitable for modeling protein complexes starting
from the free monomers. It is a multi-scale Monte Carlo-
based algorithm that combines a low-resolution, a centroid-
mode, a coarse-grain stage and a high-resolution all-atom
refinement stage that optimizes both rigid-body orientation
and side-chain conformation. Scoring in the low-resolution
phase includes residue–residue contacts and bumps,
knowledge-based terms for residue environment and
residue–residue pair propensities. In the high-resolution
phase, the energy is dominated by van der Waals energies,orientation-dependent hydrogen bonding, implicit Gaussian
solvation, side-chain rotamer probabilities and low-
weighted electrostatics energy.3. Results
3.1. Cross-linking
In the purification of ER chaperones, PDI was greatly enriched in
some fractions, but was not completely separated from a
number of other constituents as displayed by SDS PAGE (Fig. 1).
Peptide mapping of the entire fraction revealed the presence of
ERp72 (PDI A4), PDI and calnexin as the major constituent
proteinswith sequence coverages of 93, 92 and 89%, respectively
(Supplementary Fig. 1), along with trace amounts of other
proteins. The finding of calnexin was unexpected, as it is
synthesized as a transmembrane type I protein, and the
purification and characterization of this soluble form of the
protein have been described elsewhere [45].
As previous experiments on yPDI have shown great variation
in the orientation of the domains [18], the cross-linking
experiment was carried out at three different temperatures,
0 °C, room temperature and 37 °C. Each experimentwas divided
into four fractions and performed in triplicate, thus a total of 45
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Fig. 2 – Heat maps showing all observed cross-link scans (spectral observations) in PDI obtained by cross-linking with BS3 and observed with a CrossWork score of at least 10.
Total cross-link observations for all three temperatures and repeat experiments combined. Coloring is relative to the total number of observed scans. Hot spots, where at least
10 scans were observed, are shown in dark color. The horizontal and vertical lines are drawn to separate the four domains. The outermost numbering is the lysine numbers
according to the nucleotide sequence, the inner numbering is after removal of the signal peptide. Heat maps for individual temperatures and inter-protein interactions are
presented in Supplementary Fig. 2.
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Table 1 – Total number of intra and inter cross-links
observed per domain for PDI with a CrossWork score > =
10. Bottom line shows number of amino groups in each
domain (N-terminus and lysine residues).
Domain a b b′ a′
a 1067 336 295 146
b 36 111 25
b′ 325 207
a′ 33
NH2 13 8 13 15
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were recorded.
Running the native and cross-linked proteins on an
SDS-PAGE gel revealed some dimerization of PDI and the
disappearance of gel bands representing calnexin and ERp72,
indicating that there was interaction between the proteins
separated in the gel, either as homo- or as hetero-mers.
After chemical cross-linking and strong cation exchange
chromatography, followed by mass spectrometry, we identi-
fied cross-linked peptides originating from all three proteins.
Cross-linking of ERp72 and calnexin individually has been
performed previously, and the intra-protein cross-links have
been described elsewhere [18,46].
Most of the cross-links in these experiments were observed
for PDI. Combining the 15 runs from each temperature triplicate
experiment and plotting the observed number of scans (spectral
observations) for each cross-link into a grid, we generated a
heat-map for all observed cross-links (Fig. 2), along with
heat-maps for each individual experiment (Supplementary Fig.
2A–C). Data for the observed interprotein cross-links (PDI/CNX,
PDI/ERp72 and ERp72/CNX) are presented in Supplementary Fig.
2D–F. The heat maps were created in MassAI with varying
cutoffs in CrossWork score [46] and by checking the related
spectra manually. Higher CrossWork scores required for inclu-
sion in the heat map, obviously increased the confidence of the
observation, but increasing to more than 10 favored peptides
with a particularly good fragmentation rather than increasing
the confidence of identification.
3.2. Observed cross-links
Looking at the heatmap of all observed cross-links, it is clear that
most of the intra domain cross-link scans are present in the a
domain (Fig. 2, Table 1). Thiswasnot causedbya largernumber of
amino groups (lysines + N-terminus) present, as the number of
amino groups is similar to b′ and less than a′ (Table 1). Themost
likely reason could be greater detectability of the peptides, as
cross-linked peptides by their nature are larger. Looking at the
number of scans per peptide and sorting by mass, a correlation
between number of observed scans and mass can be seenFig. 3 – A. Total number of observed cross-linked peptide scans
containing the linking residue (i.e. tryptic peptide with one miss
Arginine-terminated peptides are indicated with a red ‘R’. The d
yellow (a), blue (b), orange (b′) and green (a′). List of peptides are
observed with dead-end cross-linkers.(Fig. 3A). Here is a clear trend for large peptides (>2000 Da) to be
less represented, with only three peptides (m/z 2010, 2093 and
2639) being highly represented. Both peptides 2093 and 2639 are
arginine-terminated, which could play a role due to the higher
pKa of arginine. However, when looking at the observed peptides
containing a dead-end BS3 linker (Fig. 3B), arginine-containing
peptides are not preferentially observed, and the loss of
high-mass peptides is only first observed above MH+ 2700. As
tryptic cross-linked peptides are typically triply or quadruply
charged, these cross-peptides should be well within the mass
rangeof the instrument (m/z 1800), but are clearly disfavored. The
three high-occurrence high-mass peptides thus make almost no
cross-links with other high-mass peptides, only with small mass
peptides and among themselves. Two lowmass peptides are not
observed, MH+303 and 674. The peptide MH+303 contains Lys131
and will be seen as a dipeptide (Lys-Arg), which is filtered out by
the search program as a peptide with high probability of false
identification. Peptide MH+ 674 contains Lys505 and is neither
observed as cross-linked nor as a linear peptide (Supplementary
Fig. 1). This can be due to the low mass of the peptide, but may
also be caused by its absence. The last residue observedwithhigh
confidence is residue Lys468, however, a lower confidence
peptide spans up to residue Lys502, and it is thus likely that the
KDEL sequence or a large part of the acidic C-terminal part is
missing. Calnexin purified in the same fraction is missing the
C-terminal transmembrane region [45], and for calreticulin,
obtained by the same purification scheme, it has been observed
that a fraction wasmissing the C-terminal 6 residues [48]. It thus
seems that a part of the ER proteins from the placenta is
C-terminally truncated. The low number of observed cross-links
relating to the b domain is most likely related to the fact that of
the eight lysine residues present, only three peptides with one
missed cleavage have a mass between 500 and 2000 Da
(Supplementary Table 1).
Omitting the ten cross-links least observed (i.e. two small
peptides, 8 large peptides, thus going from 48 amine groups to
38) the number of total observed scans decreases from 2581 to
2571 while the number of different observed cross-links drops
from 340 to 333. As the number of potential cross-links drops
from 1176 to 741 this means that 45% of all remaining potential
cross-links are observed at least once, indicating that a number
of short-lived interactions are likely, and onlymultiply observed
cross-links with manually validated scans are thus considered
in the following. Cross-links which are observed in at least 10
scans are in the following labeled ‘hot-spots’.
3.3. Intradomain and a–b inter-domain cross-links
Comparing the observed cross-links with the X-ray structure
of intact hPDI (PDB 4EL1) [19] shows that all observed
intra-domain hot spot cross-links fit within the allowed Cα–Cα
distance of 25 Å for the BS3 linker (Fig. 4; representativesorted after mass (M + H+) of the smallest tryptic peptide
ed cleavage) and having a CrossWork score of at least 10.
omain relation of each peptide is shown with colored letters,
shown in Supplementary Table 1. B. The same peptides
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18 - 19.3 15.6 26.2 19 17.4 12.7 16.9 22.8 25.9 22.7 25.9 39.1 30 48.1 45.9 44.8 47 33.1 39.9 40.8 63.1 64.6 57.3 50.6 49.7 64.6 65 56.9 62.3 64.9 63.4 8 77.4 70.3 78.8 77.8 71 81.1 84.5 71.7 58.4 66.6 78.1 77
31 - 18.7 22 24.8 26.8 24.8 11.5 15.7 19.9 27.5 29 45.2 33.7 51.9 49.5 42.5 44.6 31.7 34.3 31.8 55.5 56.7 49.9 42.4 39.6 53 54.5 43.3 49.6 51.5 49.1 6 60.7 54.8 60.8 59.8 55.4 64 67.1 55 41.6 48.8 59.9 58.5
42 - 27 20.5 18.1 14.9 16 13.6 13.4 13.3 14.7 27.6 17.4 34.8 33 29.5 31.9 18.8 24.5 26.8 48.7 49.4 41.8 35.3 35 51.4 51.5 43.6 48.4 51.1 50.1 7 66.9 58.2 68.9 68 62.2 72.3 74.9 61.5 48.3 57.7 70.6 70
57 - 13.3 19.2 22 12.5 17.7 22.6 24.5 26.2 52 43.6 54.5 56.9 44.9 45.3 43 42.2 34 53.3 58.3 53.8 50 48.4 51 52.1 48 54.1 60 56.2 6 61.9 58.5 67.2 65.1 51.3 62.7 68.4 55.7 45.3 51.8 61.4 60.5
65 - 6.1 10 13.7 17.8 21.2 15.3 18.4 42.9 36 46.3 48.9 40.6 41.3 37.9 39.6 34.9 53.9 58.3 53 49.2 48.9 55.3 55.5 52.3 57.6 63.2 60.5 7 70.5 65 75.7 73.9 61.1 73 78 64.5 53.3 61.3 72.2 71.6
69 - 5.4 16.7 19.2 21.5 12.1 15.7 38 32.1 42.1 44.6 38.3 39.3 35.1 38 35.3 54 57.8 52 48.2 48.4 56.8 56.7 53.5 58.4 63.8 61.6 7 73.6 67.1 78.5 76.9 65 76.9 81.4 67.7 56.2 64.8 76.3 75.7
71 - 16.4 19.5 21.6 12.9 16.7 35.6 29 41.5 42.5 38.5 40 32.5 37.1 36.1 55.9 58.9 52.4 47.7 47.8 58.9 58.9 54.2 59.1 63.6 61.8 8 75.2 68.1 79.1 77.7 67.5 78.9 83 69.4 57.2 65.9 77.7 77
81 - 9.9 15.3 19.2 21.2 43 33.2 47.9 48 39.1 40.5 32.6 34.1 29.5 51.8 54.8 48.7 43 41.3 50.8 51.7 44.3 50.4 54.5 51.7 6 62.2 56.5 65.2 63.6 54.6 65 69.2 56.2 43.7 51.5 62.7 61.7
103 - 5.7 15.2 15.4 37.3 27.9 40.4 41.1 29.8 31.1 25.8 25 19.7 42.3 44.9 38.8 33.6 32.2 42.1 42.8 35.8 41.4 46 43.4 6 56 49 59.7 58.2 49.6 60.3 63.8 50.3 37.7 46.7 59 58.5
114 - 13.9 12.9 33.2 24.4 35.3 36.3 24.2 25.5 21.7 19.7 15.2 37.7 39.9 33.6 28.5 27.7 38.8 39.2 32.6 37.7 42.4 40.3 6 54.8 46.7 58.7 57.4 49.4 60.1 63 49.3 36.9 46.5 59.4 59.2
130 - 3.8 28.6 23.2 31.1 34.1 26.3 27.3 25.3 27 25.6 43.6 46.6 40.5 37.1 38 48 47.5 44.6 48.7 54.1 52.5 7 67.2 59.1 72.2 70.8 60.5 72.1 75.7 61.7 50.1 59.7 72.3 72.2
131 - 27.5 22.5 28.6 32.2 22.7 23.6 23.9 24.2 22.6 39.9 42.9 36.9 34 35.1 44.8 44.2 41.8 45.6 51.2 49.7 7 64.8 56.4 70.1 68.7 58.5 70.1 73.5 59.5 48.1 57.9 70.7 70.7
162 - 12.2 14.4 8.4 23.7 26.6 18.1 25.3 36.3 48.1 45.5 37.7 33.8 37.1 57.2 55.8 51.2 52.6 54 55.8 8 78.5 66.7 80.8 80.5 77.3 87 87.6 74.5 62.6 73.2 87.1 87.4
170 - 22.9 16.7 23.3 26.8 8.5 19.3 29.9 47 44.7 36.1 29.6 31.3 53.2 52.6 44.8 47.6 48.5 49.6 7 71.5 60.4 72.7 72.4 70.1 79.4 80.2 67.1 54.3 64.6 78.4 78.2
195 - 12.4 16.9 18.2 25.1 25.3 33.8 38.3 36.4 30.6 30.7 35.4 50 47.8 47.6 47.7 51 52.7 74.3 62.6 78.9 78.4 73 83.1 83.9 70.8 60.8 71.4 85.1 86
200 - 21.6 24.6 19.1 23.8 36.1 44.8 40.7 33.1 29.8 33.8 54.6 53 48.5 48.9 49.7 52.2 8 76.1 63.6 78.1 78.1 76.4 85.4 85.3 72.6 61.4 72 86 86.5
207 - 3.8 20.2 12.6 17.6 24.6 23.4 16.8 16.9 21.1 34 32.3 31.2 31.8 36.6 37.1 6 57.6 46.2 62.7 62 56.4 66.3 67.2 53.9 44.1 54.7 68.3 69.3
208 - 23.9 15.7 17.9 21.7 21.7 16.3 18.5 22.7 32 30 31 31.3 37.1 37.3 6 56.7 45.6 62.7 61.8 55 65.2 66.3 53 44 54.4 67.9 69
222 - 12.3 24.2 41.9 38.8 30 22.2 23.2 46.9 46.6 37.2 39.9 40.2 41.4 6 63.9 52.5 64.6 64.4 63.7 72.3 72.6 59.8 46.9 57.2 71.1 71
230 - 14.2 30.1 27.1 18.5 11.2 12.8 34.8 34.4 26.1 28.3 30.3 31 5 53.4 41.6 55.6 55.2 53.6 62.2 62.4 49.5 37.7 48.3 62.3 62.8
247 - 23.9 25.4 20.1 17.1 16.5 24.8 25 19.1 23.2 29.5 27.3 4 43.7 34.1 48.9 47.6 41 51 52.8 39.1 28 38.5 52.1 52.7
263 - 10.5 16.1 24.7 27 14.7 11.3 23.8 21.1 30.9 29.4 4 42 32.6 51.7 50.3 41.6 50.8 51.7 39.8 36.4 44.8 56.4 58.5
271 - 9.1 18.8 21.8 19.6 17.2 22.3 17.9 24.6 25.3 4 43.5 31.8 50.3 49.7 46.6 53.9 53 41.9 37.5 46.2 58.4 60.5
276 - 10.2 14.3 23.8 22.2 20.7 18.2 22.8 24.2 4 46.1 33.5 50.9 50.5 48.9 56.5 55.6 43.8 36.5 46.2 59.4 60.9
283 - 5.5 28.8 28.3 19.5 19.5 20.7 22.5 5 46.8 34 49 48.9 49.9 57.1 56 44 34 44.2 58 58.9
285 - 28.2 28.5 16.1 17.4 17.5 18.8 4 43.3 30.6 44.4 44.4 46.8 53.4 52.2 40.3 29.6 39.7 53.5 54.3
308 - 3.8 16.4 15.2 26.3 22.2 27.7 20.2 38.8 36.9 27.4 36.1 37.3 25.3 24.3 31.1 41.9 44.2
309 - 18.6 16.6 27.7 24.3 3 31.2 23.4 42.2 40.4 30.8 39.6 40.7 29 27.8 34.9 45.6 48
326 - 7 13.9 9.2 3 27.6 15.7 31.7 30.9 31.4 37.7 36.8 24.5 16.1 25.6 39 40.4
328 - 11.2 8.3 3 28.5 15.4 33 32.5 34.4 39.6 37.8 26.7 21.4 29.6 42.2 44
350 - 6.3 3 32.2 18.7 31.1 31.9 41.5 44 40.1 31.4 25.2 32.3 44.5 45.8
352 - 3 26.7 13.2 27.2 27.4 35.2 38.2 35 25.4 19.2 26.4 38.9 40.3
366 7.4 17.3 19.5 17.1 21.2 15 10.2 13.3 26.3 21.5 22.2 25.8
370 - 13.7 16.2 13.1 16.8 12.6 9.8 6.3 19.4 14.2 17.6 20.9
375 - 19.1 18 24.6 25.7 22.5 13.6 15.4 18.1 28.3 30.6
385 - 3.8 30.1 22.9 15.8 18.4 22.9 16.8 19.1 20.3
386 - 26.4 19.3 12.8 15.1 20.9 13.8 15.9 17.5
401 - 13.6 21.2 12.7 20.8 17.4 20.2 22.5
409 - 9.7 13.2 25.8 17.4 11.4 15
415 - 14.1 26.7 18.3 13.4 17
424 - 14.2 9.9 16.9 19.6
436 - 10.6 24.6 25.3
444 - 14 14.9
467 - 3.8
468 -
Fig. 4 – Cα intra-protein distancemap for N-terminal and lysine residues for PDI structure 4EL1. Distances are color-coded as follow : green < 20 Å; yellow 20–30 Å; orange 30–40 Å;
red > 40 Å. The distances for Lys254 are based on modeling of residues 250–254, as these residues are not resolved in structure 4 L1. Numbering is the same as for Fig. 2.
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is expected, as each domain has a diameter of 25–30 Å, and
most amine groups should thus be reachable by cross-links
created by BS3.
Comparing links between the a and b domains, cross-links
between Lys200, Lys208 and Lys222 in the b domain and the
N-terminus and lysine 71, 81, 103 and 114 are abundant, but
also links to Lys31 and 130 are observed. Except for Lys103–
Lys222 all Cα distances are more than 30 Å and most exceed
40 Å (Fig. 4A), showing that the domains have tomove relative
to each other to accommodate the cross-links. As Lys71 and
Lys81 are located on the distant face of the a domain, this may
even have to rotate in order for the linkage to occur.
3.4. b–b′ inter-domain cross-links
The cross-links between the b and b′ domains are mainly
centered on Lys200 in the b domain which cross-links to
Lys247, Lys276, and Lys308. The distances to Lys247 and
Lys276 are within linking distance in the crystal model, while
Lys308 is located on the opposite side of the b′ domain (along
with the relatively high copy-linked residues Lys326 and
Lys328) indicating inter-protein interaction as no rotation
about linker regions can bring these residues into close
contact. In the X-ray structure these residues are on the
convex ‘outside’ of the dimer, and cannot be accommodated
by our dimer models (Supplementary Fig. 5), but necessitate a
different form of dimer interaction. Further three 7–9 scan
observations with a distance of 30–32 Å indicate some
flexibility in the b–b′ interface.
3.5. b′–a′ inter-domain cross-links
Although a number of cross-links can be found between the
b′ and the a′ domains, most of these are of low copy
number. However, Lys375, which is situated in the interface
between the a′ and the b′ domains, links strongly to five
lysine residues on the nearby surface of b′: 308, 309, 326, 328,
and 352, all of which are within reach in the 4EL1 structure.
Lys375 also links to Lys285, which is on the edge of the far
side of the b′ domain, which may only be reached if the a′
domain rotates and/or bends around the X-linker region.
Lys385 in the b′ domain also cross-links to a lesser degree
with the same lysines in the a′–b′ interface, but as these Cα
distances are >40 Å, it hints that the a′ domain may be able
to rotate and/or shift relative to the plane of the other three
domains.
3.6. Longer reaching inter-domain cross-links
10 hot spot cross-links are observed between the a and b′
domains (Fig. 2). Aside from the underrepresented long
peptide lysine residues 247, 254, 263, 285, and 350, the linkages
are quite evenly distributed with few strong hot spots. Lys114
and Asp18 (N-terminus) both link to Lys308 and Lys328
(distance 38–62 Å), and Lys328 in addition links to Lys31
(43 Å). These linkages are all impossible in the monomeric
structure, and even comparing to the potential dimeric
structures (distance maps in Supplementary Fig. 5) only a
single linkage can be supported.Cross-links between domains a and a′ domains are
somewhat scattered and without clear hot spots, except for
Lys467 that links to the N-terminus and to Lys103. In the
monomer, these residues are at a distance of more than 50 Å.
In the hYeastDimer model there are interacting areas
between a and a′ domains (Supplementary Fig. 5), but the
cross-links found still have distances larger than 30 Å.
3.7. Influence of temperature on cross-linking
The cross-linking of PDI was performed at three different
temperatures, 0 °C, room temperature and 37 °C.Whenmaking
a cutoff minimum score of 10, 525 scans were obtained in the
0 °C experiment, 1243 scans in the room temperature experi-
ment and 813 scans in the 37 °C experiment. The differences in
number of scans obtained are likely explained by the fact that
the 22 °C experiment had a different composition than the 0 °C
and 37 °C experiments, and for the two temperature experi-
ments, there is a difference in the reactivity of the cross-linking
reaction.
Comparing the extremes of temperatures, 0 °C and 37 °C,
only a few differences can be seen (Supplementary Fig. 2A
and 2C). Going from zero to 37 °C, most hot spots in the a
domain change, but this is mainly the result of the number of
observed cross-links in each position, as the pattern is the
same. As these residues are well within interaction range in
the PDI monomer, the increased number of cross-links at
37 °C is likely a result of increased chemical activity of BS3,
but may also be due to an increased flexibility of the PDI
molecule, as the distribution of hot spots has changed
slightly. For intra-linkages in the other domains the number
of linkages is quite small and the changes minimal.
Two residues, Lys81 and Lys208, show a much increased
reactivity at increased temperature, both of which are
stabilized in the crystal structure by salt bridges to glutamic
acid residues (Glu23 and Glu151 respectively). Raising the
temperature thus clearly diminishes this interaction, making
the lysine residues available for chemical reactions and thus
cross-linking.
3.8. Modeling of the dimeric structure
As described above, most cross-links with multiple observa-
tions can be assigned to intra-domain distances. However, of
the 27 inter-domain hot spots observed, 17 cannot be
explained by the monomeric structure. Although the crystal
structure 4EL1 shows two PDImolecules, thesemost likely do
not represent a solution dimer, and the distance map
(Supplementary Fig. 5A) does not support this either.
Based on these conclusions, we modeled the PDI dimer
using monomeric crystallized structure available in PDB
using RosettaDock. We generated 20,000 rigid body structure
predictions in a blind run of RosettaDock. For each of the
20,000 predicted structures, we checked the distances be-
tween cross-linked residues not satisfied in the monomer
(Table 2) to find the PDI homodimer model structure that
simultaneously satisfies the largest number of cross-links. In
this docking we used a cross-linking distance of 30 Å in order
to allow slightly more flexibility in the interacting molecules.
Following this strategy we expected to identify the best
Table 2 – Cross-links used for modeling the PDI dimer.
These are the cross-links that do not fit the monomer PDI
model and are observed more than five times.
Residue number Cross-link copy number
1–183 6
1–191 13
14–183 9
14–311 8
14–450 6
54–54 9
54–311 7
86–450 13
191–291 8
268–358 7
10 J O U R N A L O F P R O T E O M I C S 1 0 8 ( 2 0 1 4 ) 1 – 1 6among the 20,000 models as a result of an extensive
exploration of the conformational space.
Fig. 5 shows a heat map of the co-occurrence of all the 19
cross-links (10 cross-links A-B, 10 cross-links B-A, 1 of which is
symmetrical). As can be seen, there are 2 largemirror (A-B and
B-A) groups of cross-links, that tend to be satisfied together
and few times or never with the other cross-links. In this big
group we observe 6 cross-links which are satisfied at the same
time (themaximumobserved number) and are represented by
3 different solutions that are shown in Fig. 6. Table 3 describes
each one of them with the list of the satisfied cross-links.29
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Fig. 5 – Heat map of satisfied (Cα distance of 30 Å) cross-link co-
(co-occurrence of 2 cross-links that are under the above-mention
oranges and yellows.3.9. Inter-protein cross-links
Cross-links were also observed between both PDI and
calnexin, and between PDI and ERp72 as well as all the three
major components in the mixture, PDI, ERp72 and calnexin.
The observed cross-links are presented as heat-maps in
Supplementary Fig. 2A to 2C and the data in Supplementary
Tables 3, 4 and 5 respectively.
When cross-linking to calnexin both PDI and ERp72 show a
very uneven distribution of crosslinks, with a very high
number of observed cross-links to certain lysine residues
and none to others. Plotting these lysine residues onto the
structure of dog calnexin, which is conserved relative to the
human calnexin (e.g. all lysine residues are conserved), a
pattern can be seen where all the high copy number linkage
positions are located on the same surface close to the peptide
binding area as proposed by Chouquet et al. [49] (Fig. 7).
For PDI, the cross-linking to calnexin is clearly dominated
by interactions in the a domain (supplementary Fig. 2A), and
presenting the high-copy number linkage positions on the
structure (Fig. 8) clearly shows that the main interactions are
to the a domain and the linking regions of b–b′ and b′–a′ (the
x-linker region). For the interaction of PDI and ERp72, the
linkage pattern is much more widely distributed, but the
highest copy-number linkage positions are either identical to
PDI-calnexin or are neighboring residues.54
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Fig. 6 – Models of the PDI dimer created using RosettaDock and the constraint of cross-links defined in Table 2. A: the two PDI
molecules observed in PDB structure 4EL1. B: the model of the humanized dimer of the yeast PDI (hYeastDimer) based on 3BOA
[21]. C–E: the three modalities observed after modeling. The white PDI molecule is shown in approximately the same position
in all panels. The bottom panels (labeled A.2 to E.2) shows the model above (A.1 to E.1) rotated 180° about the vertical axis. The
a domain of each PDI molecule is indicated.
11J O U R N A L O F P R O T E O M I C S 1 0 8 ( 2 0 1 4 ) 1 – 1 6For the linking to ERp72, the twomost linking residues (Lys573
and Lys571) are located in the a′ domain and are the same for
interaction with both calnexin and PDI (although most pro-
nounced for calnexin). This is the same for the third most
reacting residue, Lys 401 in the b–b′ domain, while the nextmost
linking residues are scattered through the a and a′ domains but
with no overlap. The main interaction thus seems to be the a′
domain for the interaction with either protein but with scattered
interactions throughout the protein. These interactions are
difficult to map onto a structure, as only theoretical models of
ERp72 exist [46,50]. Mapping onto the top model reported [46]
showed no clear pattern, with several of the lysines beingpartially buried in the structure leaving the results inconclusive
(results not shown).4. Discussion
The combined use of high-resolution methods for protein
structure elucidation (e.g. X-ray crystallography, NMR spec-
troscopy), low-resolution methods (SAXS, CXMS, electron
microscopy, and others) and molecular biological methods is
needed to gain a detailed understanding of protein structure
and function. Each method has its advantages and limitations
Table 3 – Cross-links observed in each of the 3 different solutions for dimeric PDI obtained bymodeling in RosettaDock. The Cα
distances between cross-linked residuesmore than 30 Åare shown in black,whereas theones less than 30 Åarehighlighted in
red.
odel number 54_515 1_644 1_652 14_644 14_772 14_911 54_772 86_911 191_752 268_819
EL1_01827 46 9 28 28 47 78 59 89 84 75
EL1_08502 50 26 49 15 56 91 77 89 71 49
EL1_09304 23 16 30 27 74 107 62 102 81 93
odel number 462_183 462_191 475_183 475_311 475_450 515_311 547_450 652_291 729_358
EL1_01827 10 28 28 47 78 59 89 84 75
EL1_08502 9 23 27 28 68 49 69 62 32
EL1_09304 29 25 24 65 100 64 103 88 95
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4and they complement each other in several ways. An excellent
example of this is PDI. This enzymeplays an important role in the
proper folding and quality control of ER proteins and collaborates
with many other ER chaperones and folding catalysts.
Due to the importance of PDI, it has been suggested to be
involved in the development of several diseases like AIDS [51,52],
ovarian cancer [53], thrombosis [54–58], and neurodegenerative
diseases [59–62]mainly due to its important chaperone functions.
The combined use of all the methodsmentioned above has
shown PDI to contain a large hydrophobic pocket suggesting
domain b′ as the major substrate binding site [38,63–65].
Tian G et al. [18], revealed that at 4 °C the four
thioredoxin-like domains of yPDI are arranged in a twisted
‘U’ shape with domains a and a′ facing each other and the
inside surface of the ‘U’ shape containing a high abundance of
hydrophobic residues, thus providing binding sites for sub-
strate proteins, while at 22 °C the domain a rotates 123°
around the junction between domains a and b, and hence the
four domains form a ‘boat’ shape. It was demonstrated that
the junction between domains a and b is even more flexible
than the one between domains b′ and a′, which was critical
for the enzymatic activity both in vivo and in vitro. Wang C et
al. [19] revealed that the four domains of hPDI were arranged
as a horseshoe shape, with two CGHC active sites, located in
domains a and a′ respectively, facing each other, but hPDI
exists in different conformations under oxidized and reduced
states. The oxidized human PDI exists in an open state with
more exposed hydrophobic areas and a larger cleft with
potential for substrate binding, in which the four domains
stay in the same plane, and the two active sites are 40.3 Å
apart, while the reduced hPDI exists in a closed state, in which
domains a, b and b′ line up in the same plane, whereas
domain a′ twists around 45° out, and the distance between the
two active sites is 27.6 Å. The redox-regulated open/closed
conformations facilitate the protein's binding capacities for
versatile targets. These conformation changes are facilitated
by the mobility around the linker region [66].
Here we have analyzed hPDI co-purified with calnexin and
ERp72 by chemical cross-linking and mass spectrometry. We
have used the lysine-reacting compound bis [sulfosuccinimidyl]
suberate (BS3) which cross-links amino groups (i.e. N-terminus
and lysine residues). A feature of cross-linking with BS3 is that
the reaction is relatively slow with reaction times of more than
1/2 h (in this experiment BS3 was allowed to react for one hour).
If the protein has a very stable structure, wewill observe specificinteractions, i.e. only relatively few cross-links. However, if the
structure is flexible, intra-domain cross-links are expected to
dominate, as the linking points have a relatively stable position
relative to each other, while inter-domain cross-links are less
frequent if the domains are flexible and have activemovements
relative to each other while the reaction takes place. Another
bias that has to be considered, is that high-mass peptides are
disfavored in cross-linked peptides (Fig. 3A), which however
cannot be observed for the peptides derivatized by a hydrolysed
BS3 molecule (dead-end linkers).
In the case of PDI, particularly the a and a′ domains have
been shown to be mobile relative to the b–b′ domains
[13,38,66]. Thus we can expect a large number of low
frequency cross-links spanning a large number of lysines. In
the present experiment we cross-linked with BS3 digested
with trypsin and after LC–MS/MS analysis we searched the
data with the MassAI program, which has incorporated an
updated version of CrossWork [46] using a score cutoff of 10.
This resulted in 340 different PDI cross-links in 2581 observed
scans (ms/ms spectra). To establish an overview of these
results, they are presented as heat maps, colored according to
the number of observed scans (Fig. 2, Supplementary Fig. 2). A
large part of these cross-links is of low copy number andmost
likely represent short-term spatial arrangements of PDI,
PDI-PDI interactions or false positives. For this reason we
have focused on ‘hot spots’, i.e. cross-links observed in more
than 10 scans.
The present results have been compared to the full-length
structure of oxidized hPDI structure, PDB code 4EL1 [7,19]. This
structure is based on recombinant PDI expressed without the
signal peptide, but with an N-terminal purification tag.
However, as the PDI used in the current analysis was purified
from human placenta, there may be slight structural differ-
ences. We also chose to compare to the oxidized form, as this
has been analyzed in a tris–HCl, pH 8.0 buffer, while the
reduced PDI (PDB 4EKZ) has been analyzed in the presence of
50 mM DTT. When compared to the reduced form (distance
map in Supplementary Fig. 4), only minor differences can be
seen, and no additional cross-link mapping can be assigned.
Comparing the combined cross-links (Fig. 2) to the lysine
Cα distances in PDI (Fig. 4A) it can be observed that all
observed intra-domain hot-spot linkages fit with the 4EL1
structure. However, when comparing interactions between
domains, only 10 out of 27 cross-links are still supported by
the monomer model. The non-explained cross-links are most
Fig. 7 – Inter-cross-linking sites oncalnexinmodel 1JHN.Thegeneral structure is shownasbackbone, lysine residues aredisplayed
in space filling mode. Low scan number cross-linking lysines are shown in blue. High scan number lysine residues unique for
cross-links to PDI are shown in green, unique for ERp72 in cyan, common for both PDI and ERp72 are shown in orange.
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supported by the SDS PAGE gel (Fig. 1). In the X-ray crystal of
hPDI (4EL1), two PDI molecules in the asymmetric units are
oriented in a concave fashion. A dimerized yPDI was also
suggested by Tian and co-workers [21] which also showed a
dimer with the a domain nestled in the concave cavity of the
opposite PDI. We subsequently modeled the hPDI sequence
into the yeast dimer and calculated lysine–lysine distances.
However, as neither model could satisfy our cross-linking
results, it led us to model alternative PDI dimer models using
Rosettadock. We identified 10 cross-links that could not be
accommodated by the monomer structure and were deter-
mined to be reliable and stable (Table 2). We generated 20,000
models and sorted them according to their fit to the
cross-links (Fig. 5). This resulted in three modalities (Fig. 6)
showing that instead of the dimer models, where the a
domain of one PDI molecule is nestled inside the U form of
another PDI molecule (Fig. 6A), we have interaction between
the outside of the a–b domains. Either domain a against b in
an antiparallel fashion (Fig. 6B and D), or slightly cross-wise
centered on the a–b linker region (Fig. 6C). None of the dimer
models satisfied all of the ‘missing’ cross-links (Table 3),
indicating that we have a number of different interactions.
Furthermore, we are likely to have alternative conforma-
tions of PDI, as the present modeling was performed basedon a rigid-body docking that did not take intra-chain
flexibility into consideration. As a large number of the
observed cross-links indicate that we have considerable
flexibility, it is likely that this could satisfy the missing
cross-links.
As the crystal structure of the yPDI showed distinct
differences in structure when crystallized at 0 °C and at room
temperature, we performed the cross-linking experiment at 0
and 37 °C. Based on the heat maps (Supplementary Fig. 2A and
2C) it can be concluded, that there are no great differences in the
solution structures at either temperature. The main difference
observed is a markedly lower cross-linking ability of residues
Lys81 and Lys208 at 0 °C, which is likely caused by a stronger
stabilization by salt bridges to glutamic acid residues at low
temperature.
A large number of inter-protein cross-links were also
observed between the major components of the fractions
(PDI, calnexin and ERp72). For all interactions involving
calnexin, the cross-linking was clear to the surface of the
molecule containing the peptide and carbohydrate binding
area [49,67] (Fig. 7), thus confirming this part as the main
peptide interaction region. For PDI the interactions with ERp72
and calnexin were mostly similar, with the a domain being by
far the strongest cross-linker (Fig. 8). For ERp72 the situation
was different, as the main interaction to PDI shared only part
Fig. 8 – Inter cross-linking sites onmonomeric PDImodel 4EL1. The general structure is shown as backbone, lysine residues are
displayed in space-filling mode. Low scan number cross-linking lysines are shown in blue. High-scan number lysine residues
unique for cross-links to calnexin are shown in green, unique for ERp72 in cyan, common for both calnexin and ERp72 in
orange. The a domain is shown at the bottom right.
14 J O U R N A L O F P R O T E O M I C S 1 0 8 ( 2 0 1 4 ) 1 – 1 6of the interaction with calreticulin. Although most of the
participating lysines were cross-linking for both proteins, the
distribution of the intensities was quite different with the
interaction to calreticulin being more localized, in agreement
with calreticulin being a smaller molecule with a single
globular domain. The binding residues were the same,
particularly in the a domain, but the distribution of linked
residues was slightly different as observed for calreticulin,
probably reflecting the size of the binding proteins.
Although there seems to be no reports on a biological
interaction of PDI, ERp72 and calnexin, the fact that they
co-purify through a lengthy purification process, indicates
that the interaction is both specific and stable. In our
purification of placental chaperones, we have observed
other protein mixtures, which may represent similar com-
plexes. Another question is whether it is possible to analyze
the binding PDI to substrate proteins by CXMS. In this case
the interaction is expected to be rather short-lived, and the
use of a fast reacting cross-linker is thus necessary. The
most likely choice would be photoreactive cross-linkers,
however, they are quite unspecific, which will lead to a
lower yield of the individual cross-link and a much larger
search space for the search program. Combined with the
large size of PDI, this seems to be out of reach by the current
technology.5. Conclusion
The current results show that it is possible to generate a
wealth of data using standard cross-linking techniques when
combined with sensitive mass spectrometric analysis and
detection software. For the analyzed hPDI protein an X-ray
structure of the intact protein exists, and the current
experiments are for a large part consistent with the model.
PDI is a very flexible molecule as the a and a′ domains can
move through large angles relative to the b and b′ domains.
X-ray experiments have shown a large variation in the
orientation of the a and a′ domains relative to the b and b′
domains, both regarding temperature (for yPDI) and oxidation
state (for hPDI). Based on the current results, we hypothesize
that the different conformations observed in X-ray structures
may be ‘frozen’ conformations that may be entered under
most/all conditions, and which happen to be stabilized under
the specific crystallization conditions used. Furthermore, the
structure of the yeast dimer is unlikely to be representative of
the hPDI dimer. Although the substrate interaction generally
has been located to the b′ domain, the present results indicate
that the in-solution homo-dimer does not bind in this area,
but in the domain a–b interface. Our data thus suggest a
convex dimer interaction rather than a concave.
15J O U R N A L O F P R O T E O M I C S 1 0 8 ( 2 0 1 4 ) 1 – 1 6Interaction was observed between all the major compo-
nents in the mixture. While the interaction to calnexin was
clearly localized, the interaction to PDI was more diffuse over
the a′ and part of the b′ domain. Interaction to Erp72 was
difficult to determine, as a complete structural model is not
available yet.
In conclusion, cross-linking in combination with mass
spectrometry is a valuable supplement to other structural
methods and can be used to obtain information about protein
structure, flexibility and interaction, as exemplified here for
PDI, calnexin and ERp72.Transparency document
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